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Abstract
Background: Polyethylenimine (PEI) is one of the most efficient and versatile non-viral vectors
available for gene delivery. Despite many advantages over viral vectors, PEI is still limited by lower
transfection efficiency compared to its viral counterparts. Considerable investigation is devoted to
the modification of PEI to incorporate virus-like properties to improve its efficacy, including the
incorporation of the protein transduction domain (PTD) polyarginine (Arg); itself demonstrated to
facilitate membrane translocation of molecular cargo. There is, however, limited understanding of
the underlying mechanisms of gene delivery facilitated by both PEI and PEI-bioconjugates such as
PEI-polyarginine (PEI-Arg) within live cells, which once elucidated will provide valuable insights into
the development of more efficient non-viral gene delivery vectors.
Methods: PEI and PEI-Arg were investigated for their ability to facilitate DNA internalization and
gene expression within live COS-7 cells, in terms of the percentage of cells transfected and the
relative amount of gene expression per cell. Intracellular trafficking of vectors was investigated
using fluorescent microscopy during the first 5 h post transfection. Finally, nocodazole and
aphidicolin were used to investigate the role of microtubules and mitosis, respectively, and their
impact on PEI and PEI-Arg mediated gene delivery and expression.
Results: PEI-Arg maintained a high cellular DNA uptake efficiency, and facilitated as much as 2-fold
more DNA internalization compared to PEI alone. PEI, but not PEI-Arg, displayed microtubule-
facilitated trafficking, and was found to accumulate within close proximity to the nucleus. Only PEI
facilitated significant gene expression, whereas PEI-Arg conferred negligible expression. Finally,
while not exclusively dependant, microtubule trafficking and, to a greater extent, mitotic events
significantly contributed to PEI facilitated gene expression.
Conclusion: PEI polyplexes are trafficked by an indirect association with microtubules, following
endosomal entrapment. PEI facilitated expression is significantly influenced by a mitotic event,
which is increased by microtubule organization center (MTOC)-associated localization of PEI
polyplexes. PEI-Arg, although enhancing DNA internalization per cell, did not improve gene
expression, highlighting the importance of microtubule trafficking for PEI vectors and the impact of
the Arg peptide to intracellular trafficking. This study emphasizes the importance of a holistic
approach to investigate the mechanisms of novel gene delivery vectors.
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Background
Gene therapy has the potential to treat many inherited
and acquired genetic diseases. While applications of non-
viral gene delivery are routinely used for a vast range of
protocols within the general research environment, the
progression to clinical therapeutic applications remains
elusive. The realization of such a therapeutic approach is
hampered by the lack of understanding of the mecha-
nisms by which gene delivery vectors actually function.
Despite similarities between vectors in terms of a typical
gene delivery strategy, which are acknowledged to
include: the packaging of exogenous DNA, specific target-
ing to cells and/or tissue, cellular uptake through the
plasma membrane, intracellular transport, and finally
nuclear import and transcription of the exogenous DNA
into therapeutic products, all vectors have discrete charac-
teristics that must be initially optimised for each applica-
tion. Despite the widespread use of commercially
available gene delivery vectors for basic science, research-
ers often are content to have a vector that simply works,
and not question the fundamental delivery mechanisms
of the vector itself.
The cationic polymer polyethylenimine (PEI) is among
the most efficient and versatile non-viral vector (for
reviews see [1,2]), and has been shown to be effective for
DNA delivery both in vitro [3,4] and in vivo [5-7]. While its
ability to electrostatically bind and condense DNA [8], as
well as facilitate endosomolysis to avoid lysosomal degra-
dation [9,10], are major contributing factors to its relative
greater efficacy over other non-viral vectors, very little is
understood regarding the mechanism of internalization,
the mode of transport throughout the cytoplasm, and the
final entry into the nucleus.
Post endosomolysis, the mechanism of nuclear localiza-
tion and subsequent entry of PEI polyplexes is not clear.
Motor driven transport through the cytoplasm via interac-
tion with microtubules has been suggested [11,12], how-
ever, the exact mechanism has not been elucidated. Active
nuclear uptake is questionable [2] and various hypotheses
of interactions with the nuclear pore complex, or the
nuclear membrane itself, have been suggested [13]. Insuf-
ficient knowledge of these mechanisms limits the poten-
tial of PEI, and hence, further investigation is necessary to
develop PEI towards becoming an effective therapeutic
agent for gene therapy.
In the quest to bridge the efficiency gap between PEI and
viral vectors, extensive research has been focused on the
modification of PEI, with the aim of introducing novel
properties to the vector. For a range of reviews discussing
PEI modification, see [1,2,14]. Protein transduction
domains (PTDs) are polypeptides that have the capacity
to facilitate delivery and translocation of molecular cargo,
both to and into the cytoplasm, and in some cases, the
nucleus. The use of PTDs has significant potential for the
basic investigation of cellular processes; moreover, they
are of great interest because of their potential for the deliv-
ery of therapeutic molecules. While the exact mechanism
of cellular internalization is unknown, PTDs have been
suggested to mediate receptor-independent internaliza-
tion via electrostatic interactions with negatively charged
phospholipids and/or carbohydrate components on the
cell surface [15]. Well-documented PTDs include the viral
HIV-1 Tat DNA binding domain, and HSV-1 VP22 tegu-
ment protein, the Antennapedia DNA binding domain
from Drosophila, and the synthetic polyarginine (Arg) pep-
tides [16-19]. These PTDs have been used to deliver an
extensive range of active molecules, including p53, Bcl-xL,
Cre recombinase, and HOXB4 [16,20-25], to successfully
influence a range of cellular processes.
In particular, synthetic Arg peptides have been demon-
strated to be at least as effective as the HIV-1 Tat peptide
[25-27]. Despite a well-documented ability to translocate
membranes, the mechanism of Arg internalization and
subsequent nuclear localization remains debatable. It has
been traditionally accepted that Arg, and many other
PTDs, demonstrate rapid cellular internalization (within
minutes)[25], in addition to uninhibited uptake at 4°C
[24]. This suggested an endocytic-, and receptor-inde-
pendent internalization mechanism. Furthermore, Arg
has been observed to localize within both cytoplasmic
and nuclear compartments in fixed-cell studies [25-28].
Live-cell studies, however, show that Arg peptides exclu-
sively localize within endocytic vesicles [29,30], and
hence, the above cytoplasmic and nuclear observations
have been suggested to be a function of fixation artefacts.
While the use of the PTD Arg within a gene delivery strat-
egy may be viable, further investigation is needed to
extend the current understanding of Arg internalization
within live cells. In addition, it is important to determine
the fate of Arg peptides once internalized and, just as cru-
cial, their potential for nuclear accumulation.
In this study, the ability of PEI and PEI-Arg bioconjugates
to deliver plasmid DNA, in terms of cellular uptake, intra-
cellular trafficking and biodistribution, and expression of
exogenous DNA, was examined. More specifically, the
efficiency of PEI and PEI-Arg polyplex-facilitated transfec-
tion was determined. The total percentage of cells with
internalized reporter plasmid and the relative level of
expression were examined using labelled DNA and a GFP
reporter plasmid. In addition, the amount of plasmid
internalized and expressed per individual cell was deter-
mined, in order to further characterize the efficiency of
polyplex-facilitated DNA delivery. Intracellular trafficking
pathways of both fluorescently-labelled DNA and poly-
mers were studied, to investigate trafficking of PEI/pDNAGenetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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and PEI-Arg/pDNA complexes and their ability to reach
the nucleus, a pre-requisite for expression of the exoge-
nous DNA. Finally, the effects of microtubules and mito-
sis were examined to determine the significance of their
contribution to PEI and PEI-Arg facilitated gene expres-
sion. Our data suggest that the resulting expression of
exogenous DNA by PEI bioconjugates is dependant on
microtubule trafficking. Despite an increase in the
amount of DNA internalized by PEI-Arg polyplexes, the
lack of active transport mechanisms as a result of a differ-
ent alternative internalization mechanisms, contributed
to a very low PEI-Arg facilitated gene transfection and
expression.
Methods
DNA constructs utilized in this study
The plasmid pCH110 was fluorescently labelled with the
DNA intercalator YOYO-1 iodide for uptake analysis by
PEI and PEI-bioconjugate polyplexes (see section below).
The plasmid pEOTCGFP was used for quantitative expres-
sion analysis. It contains a mitochondrial ornithine tran-
scarbamylase targeting signal with an in-frame GFP
construct. Plasmids were purified from bacterial culture
(DH5α) using Qiagen reagents and stored in deionised
H2O at -20°C.
Conjugation of poly-arginine peptides to PEI
Polyethylenimine (PEI; 25 kDa; Sigma) was conjugated to
Arg peptides (RRRRRRRRRRRGC) using the heterobifunc-
tional crosslinker N-succinimidyl 3-(2-pyridyldithio)pro-
pionate (SPDP; Sigma), using a protocol modified from
[31]. In brief, 3 ml of a 500 mM PEI stock solution in
HEPES buffer 1 (350 mM NaCl, 20 mM HEPES, pH 8) was
added to 2 ml of 20 mM SPDP in dimethyl sulfoxide
(DMSO), and incubated at room temperature on a orbital
plate shaker overnight. Un-conjugated SPDP was
removed by gel filtration using a G-25 Sephadex column
equilibrated with HEPES buffer 2 (250 mM NaCl, 20 mM
HEPES, pH 7.4), and was eluted in 3.5 ml of the same
buffer. The degree of modification was determined by
spectrophotometric analysis at 343 nm by release of pyri-
dine-2-thione after reduction by excess dithiothreitol
(DTT, 100 mM) for 30 min.
Peptide conjugation was completed by combining a 1 ml
aliquot of PEI-SPDP solution with 4 mg of peptide at a 5-
fold molar excess of peptide to PEI-SPDP. The peptide/
PEI-SPDP solution was incubated at room temperature on
an orbital plate shaker overnight. The extent of peptide
conjugation to PEI-SPDP was determined by the release of
pyridine-2-thione measured spectrophotometrically at
343 nm. PEI-peptide conjugates were stored at 4°C.
Fluorescent labelling of DNA and PEI
Plasmid pCH110 was fluorescently labelled with the
intercalating nucleic acid dye YOYO-1 iodide (diluted
from 1 mM stock solution in DMSO; Molecular Probes).
500 μl of pCH110 (0.1 mg/ml) was combined with 100
μl of 10× TAE buffer and 400 μl of 10 μM YOYO-1 dye in
TE buffer in a microcentrifuge tube. The solution was
mixed for at least 1 h at room temperature in the dark, and
stored wrapped in foil at -20°C.
PEI was fluorescently labelled with the amine reactive
probe, Oregon Green 488 carboxylic acid succinimidyl
ester *5-isomer* (Molecular Probes, [13]). PEI was
diluted to a concentration of 10 mg/ml in 0.1 M sodium
bicarbonate pH 8.3. A 1 ml aliquot of PEI solution was
transferred into a microcentrifuge tube, and, 50 μl of the
prepared probe (dissolved in DMSO to a final concentra-
tion of 10 mg/ml) was added. The solution was incubated
at room temperature on an orbital plate shaker for 1 h
protected from light, and subsequently stored at 4°C.
COS-7 cell maintenance
The experiments described were performed in vitro using
adherent African Green Monkey kidney fibroblast cells
(COS-7). The COS-7 cell line was cultured in Dulbecco's
Modified Eagle Medium (DMEM; Multicel Thermo Trace)
supplemented with fetal bovine serum (to 5%; Thermo
Trace) and penicillin/streptomycin (5000 U/ml each;
CSL). Cells were grown at 37°C in a 5% CO2 atmosphere,
and were passaged 3 times weekly for 4 weeks.
Transfection using PEI
PEI and DNA solutions were prepared before each experi-
ment at various molar ratios of PEI nitrogen (N) to DNA
phosphate (P) (where 1 μg DNA equals 3 nmol of phos-
phate, and 1 μl of PEI stock contains 10 nmol of amine
nitrogen, based on a 10 mM stock solution as defined in
[5]). Based on this, the following calculation was used to
determine the required volume of PEI from a stock solu-
tion [Volume of PEI of 10 mM stock (μl) = (desired N/P/
3.3) × (μg DNA/1)].
For FACS analysis, cells were seeded in 24 well plates at 4
× 104 cells per well 24 h before transfection. 2 μg pDNA
was initially diluted into 100 μl of 150 mM NaCl and vor-
texed, followed by the addition of polymer solution to
reach a desired N/P ratio, as described above. The solution
was vortexed and centrifuged briefly, and was allowed to
complex at room temperature for 30 min, after which the
transfection mixture was added to the cells.
For microscopic analysis, cells were seeded in a 6 well
plate on top of a sterilized coverslip at 1–2 × 105 cells per
well, 24 h before transfection. 200 μl of 150 mM NaCl wasGenetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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used to dilute 3 μg of pDNA. The transfection protocol for
24 well plates was then followed.
Transfection using Lipofectamine 2000
2 × 105 cells were seeded in a 60 mm dish that contained
a sterilised coverslip 24 h before transfection. Amounts
indicated per dish are as follows: 4 μg of pDNA (pCH110;
fluorescently labelled) and 10 μl of Lipofectamine 2000
(Invitrogen) was diluted in separate sterile microcentri-
fuge tubes, each containing 250 μl of incomplete DMEM
(serum negative; penicillin/streptomycin negative; 3.67 g/
l sodium hydrogen carbonate). Each of the solutions were
gently inverted and incubated at room temperature for 5
min. The Lipofectamine solution was then added to the
pDNA solution, mixed by inversion, and incubated for a
further 20 min at room temperature. Lipofectamine/
pDNA solution was added to cells, and after 4 h cells were
washed three times with PBS, and media replaced with
serum positive DMEM.
Preparation for transfection with addition of nocodazole 
and aphidicolin
The microtubule depolymerizing agent nocodazole (10
mM stock in DMSO; Sigma) was used to investigate the
role of microtubules on intracellular trafficking and GFP
expression. Cells were seeded 24 h before transfection. 2
h before transfection, media was removed and replen-
ished with fresh DMEM containing nocodazole (final
concentration 10 μM, [32]). Cells were analysed by fluo-
rescent microscopy 5 h post transfection. For analysis of
GFP expression, cells were washed 3 times with PBS 4 h
post transfection and replenished with fresh DMEM con-
taining nocodazole (10 μM). Cells were analysed by FACS
24 h post transfection.
The cell cycle disrupting agent aphidicolin (10 mM stock
in DMSO; Sigma) was used to determine the role of
nuclear membrane breakdown on GFP expression [33].
Cells were seeded in DMEM containing 10 μM aphidico-
lin 24 h before transfection. 2 h before transfection, media
was replaced with fresh DMEM containing 10 μM aphidi-
colin. 4 h post transfection, cells were washed and media
replaced with fresh DMEM containing 10 μM aphidicolin.
Cells were analysed by FACS 24 h post transfection.
Preparation and visualization of live cell samples
The intracellular trafficking of polyplexes was studied by
fluorescent microscopy. Cells were transfected with
labelled DNA/PEI complexes and observed using the
Olympus BX-50 fluorescence microscope fitted with a
SPOT RT 3CCD camera (Diagnostic Instruments) and
processed using SPOT Advanced software (version 3.4) at
1 h, 2 h, 3 h, 4 h, and 5 h post transfection.
Preparation of samples was as follows: Cells were seeded
on top of sterilized coverslips and transfected as described
above. 30 min prior to viewing cells, MitoTracker
CMXRos (in DMSO; 10 mM, Molecular Probes) was
added directly to cells in DMEM at a working concentra-
tion of 20 nM. Immediately before viewing, coverslips
with cells were washed 4 times with PBS, and were lightly
blot-dried by touching the coverslip on its edge to a tissue.
The coverslip was gently placed, inverted, on a micro-
scopic slide, and nail polish was used to seal the edges of
the coverslip to the slide. Samples were viewed at 100×
magnification by oil immersion.
Preparation of fixed cell samples for immunofluorescence 
assay
An immunofluorescence assay was used to visualize
microtubules. Cells were seeded on top of a sterilized cov-
erslip at a cell density of 1 × 105 per well, 24 h prior to fix-
ation. All subsequent steps were completed at room
temperature. The media was removed, and the coverslip
was washed 3 times with filtered PBS. (N/B – after each of
the following steps, the coverslip was additionally washed
3 times with filtered PBS). Cells were fixed for 10 min with
1 ml of 4% paraformaldehyde. Cells were then permeabi-
lized for 5 min with 1 ml of 0.2% Triton ×100 in PBS. 50
μl of a 1/100 dilution of mouse monoclonal anti-β-tubu-
lin primary antibody (diluted in 0.2% Triton-3% BSA
solution; Sigma) was added and allowed to incubate for 1
h. Finally, 50 μl of a 1/200 dilution of FITC-conjugated
secondary antibody was added and incubated for a further
30 min. The coverslip was washed and mounted on a
microscopic slide as described above.
Fluorescence activated cell sorting (FACS) analysis
FACS analysis was used to quantify PEI and PEI-Arg facil-
itated cellular internalization and gene expression trans-
fection efficiency. Cells were washed thoroughly 4 h post
transfection with PBS to remove unbound and surface-
bound polyplexes. After 24 h, each well was further
washed twice with PBS, and trypsin was added to detach
cells. Cells were resuspended and collected in PBS, and
subsequently analysed using a FACS Calibur flow cytom-
eter (Beckton Dickinson). Cytometric data was analysed
using CELLQuest software. Cells were collected to a desig-
nated 10,000 events or 180 seconds of passage time.
Results and discussion
PEI-Arg bioconjugate effectively promotes pDNA uptake 
in a very high percentage of cells
Internalization of polyplexes was analysed in this study
with the aim to determine both the proportion of cells
within the population that display pDNA internalization,
and the efficacy of internalization of labelled DNA per
positively transfected cell. FACS analysis was used to
examine internalization of PEI and PEI-Arg polyplexes,Genetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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detected by the presence of fluorescently labelled
pCH110, which had been complexed with polymer prior
to transfection. In addition, the analysis investigated any
potential trends that may occur across a range of N/P
ratios from 0 through to 14, which encompasses a com-
mon range in which PEI is used throughout the literature.
Both PEI and PEI-Arg polyplexes were internalized by
92.23% (± 4.66) and 92.75% (± 2.65) of cells respectively
(Figure 1a) across the range of N/P ratios tested, but only
after the N/P ratio was above 4. Below an N/P ratio of 4,
internalization of both polyplexes is poor, and the per-
centage of cells fluorescing is almost negligible at N/P of
1. This correlates strongly with the neutralization in over-
all polyplex charge observed in gel mobility assays (data
not shown), both supporting the reported data that a net
positive polyplex charge is a prerequisite for efficient
internalization [5].
Importantly, the addition of Arg peptides did not seem to
negatively affect the uptake ability of native PEI. As both
polyplex configurations displayed a high percentage of
cells fluorescing (>92%), it is likely that uptake had
reached a saturation point limited by the maximum pos-
sible exposure of polyplex to cells. Further enhanced poly-
plex uptake is likely to have been hampered by
aggregation and layering of cells in culture.
PEI-Arg polyplexes are internalized two-fold more 
efficiently than PEI polyplexes
The efficiency of polyplex internalization was determined
by examining the relative amount of fluorescently
labelled DNA internalized within each cell. This was cal-
culated as a relative ratio by dividing the total mean fluo-
rescence by the percentage of cells fluorescing. This ratio
therefore gave an indication of mean fluorescence per
individual cell, and hence provided a relative but sensitive
means to detect changes in the actual amount of fluores-
cence per cell. Furthermore, a direct comparison of trans-
fection by both polyplex types could be examined (Figure
1b). PEI polyplexes displayed a ratio of approximately 2.0
across the N/P ratios tested above N/P 3.0, however, PEI-
Arg displays a doubling of ratio above PEI from N/P
4.0–8.0, which decreased above N/P 8. The number of
PEI-Arg polyplexes internalized per cell was greater than
that internalized by PEI polyplexes by approximately 2-
fold. This therefore suggests that the addition of the Arg
peptide enhances the amount of polyplexes internalized,
and hence increases the amount of pDNA within the cell
available to be delivered to the nucleus.
Interestingly, there was no significant difference in the
percentage of cells positively fluorescing above an N/P
ratio of 4 for PEI and PEI-Arg, and there was not a signifi-
cant difference in the amount of polyplexes internalized
across the N/P range tested (above N/P 4). Therefore, we
Efficiency of PEI- and PEI-Arg polyplex internalization Figure 1
Efficiency of PEI- and PEI-Arg polyplex internalization. The percentage of fluorescently positive cells (A) and the rela-
tive amount of fluorescence per fluorescently positive cell (B) were calculated for polyplexes composed of PEI ( ) and PEI-Arg 
( ) complexed with YOYO1-labelled pCH110, as detected by FACS 24 h post transfection. Data points represented as mean 
values ± SEM (N = 3).
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surmise that the presence of a positive charge alone is nec-
essary for internalization, and that the increased charge
with greater N/P ratios does not further promote internal-
ization. Furthermore, it is possible that the maximal poly-
cationic compaction of pDNA has been reached, such that
the complex size is reduced to a level that further positive
charge it is no longer a factor in the translocation of DNA
into the cell or into the nucleus. Both of these observa-
tions have important implications for the use of PEI and
polyplexes  in vivo. An increased net positive polyplex
charge has a greater association with toxicity by extra- and
intracellular non-specific charge-related interactions
[34,35], and hence transfection with the lowest possible
net polyplex charge that still facilitates efficient internali-
zation is crucial to successful efficient delivery of exoge-
nous DNA.
PEI but not PEI-Arg polyplexes localize specifically to 
within proximity of the nucleus
Intracellular trafficking of PEI and PEI-Arg were analysed
by fluorescence microscopy at hourly time intervals dur-
ing the first five hours post transfection. An N/P of 8 was
used for each transfection, a ratio previously established
to be most suitable for microscopy analysis [13]. The
intracellular trafficking of individually labelled PEI/pDNA
and labelled pDNA/PEI polyplexes was initially analysed,
from which the trafficking of labelled pDNA/PEI-Arg
could be compared.
Within one hour, labelled pDNA/PEI complexes were
seen to be interacting with the cell surface and within the
cytoplasmic periphery (Figure 2 – PEI/pDNA-YOYO),
with evidence of polyplex aggregation in specific areas of
the cell surface, seen in Figure 2 (1 h). Complexes were
seen to be internalized at 2 hours, and, within 4 hours,
significant localization within the nuclear proximity was
observed, highlighted by the accumulated fluorescence
observed in the DNA and merged photographs (Figure 2
– PEI/pDNA-YOYO 4 h). The distribution of fluorescence
was not uniform around the perinuclear region, but co-
localized within a region corresponding to the microtu-
bule organization center (MTOC), providing evidence of
microtubule involvement in PEI trafficking. The MTOC is
located adjacent to the nucleus, and is indirectly identified
in the MitoTracker images (Figure 2) as a ring of densely
stained mitochondria surrounding a region of markedly
fewer mitochondria.
Although it was demonstrated that the labelled pDNA,
which was presumed to be part of the PEI/pDNA-labelled
polyplex, were localizing to the perinuclear/MTOC-asso-
ciated region, it was essential to confirm that PEI itself,
when complexed with fluorescently labelled DNA, was
also trafficked to the MTOC-associated region. PEI was
labelled with the fluorescent probe Oregon Green 488,
complexed with unlabelled pDNA, and was viewed under
the same time conditions (Figure 2 – PEI-labelled/pDNA).
PEI-labelled/pDNA polyplexes were seen to be within the
cytoplasm at the first hour, which was observed earlier
than PEI/pDNA-YOYO polyplexes. Interestingly, MTOC-
associated accumulations were also seen as early as two
hours, which was detected earlier than PEI/pDNA-YOYO
polyplexes. We suggest that this observation is due to
uncomplexed PEI being rapidly internalized prior to PEI/
pDNA polyplexes, providing visual evidence in support of
the work of Boeckle et al. [35], who demonstrated the
importance of un-complexed PEI in promoting efficient
transfection with PEI.
The commercially available cationic lipid Lipofectamine
2000 was used to determine if MTOC-associated localiza-
tion of PEI/pDNA was a property of PEI polyplexes alone
(Figure 2 – Lf2000/pDNA-YOYO). In contrast to cationic
polymer-mediated delivery, lipoplexes did not display
similar MTOC-associated accumulation, but appeared to
be randomly dispersed throughout the cell. Interestingly,
lipoplexes did show some nuclear localization as early as
3 h post transfection, whereas PEI polyplexes did not dis-
play any significant nuclear localization over the entire
five hours analysed. Lack of specific MTOC-associated
accumulation by lipid mediated transfection suggests that
localization exhibited by PEI polyplexes to the MTOC-
associated region might indeed be PEI specific.
The Arg peptide was conjugated to PEI to enhance the
membrane transductional properties of PEI. Analysis of
PEI-Arg complexed with labelled pDNA revealed that
while polyplexes were observed inside the cell periphery
(within the same time period as PEI throughout the time
course studied), no MTOC-associated fluorescence accu-
mulation was observed (Figure 2 – PEI-Arg/pDNA-
YOYO). Even at the 5 h time point, labelled pDNA was
found to be widely distributed throughout the cytoplasm.
We therefore conclude that differences in the internaliza-
tion mechanisms between both PEI and PEI-Arg ulti-
mately affect the subsequent intracellular trafficking of the
respective polyplexes.
It is accepted that a significant feature of PEI which con-
tributes to its gene delivery efficiency is its ability to act as
a proton sponge within the endosome [9,10,36]. Endo-
somes become acidic as they migrate and mature into late
endosomes, which in turn initiates proton capture by PEI,
facilitating the proton sponge effect, and subsequently
initiating endosomolysis. The absence of MTOC-associ-
ated localization by PEI-Arg/pDNA polyplexes, and hence
lack of PEI-Arg/pDNA trafficking to the nuclear periphery,
suggests that the Arg mediated internalization mechanism
is different to that of PEI polyplexes alone. We suggest that
the Arg internalization does not follow a traditional endo-Genetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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Intracellular trafficking of PEI- and PEI-Arg polyplexes Figure 2
Intracellular trafficking of PEI- and PEI-Arg polyplexes. Time points were taken on the hour, for the first 5 hours post 
transfection, and viewed by fluorescent microscopy. Merged images were constructed from individual labelled-PEI-, or labelled-
pDNA-, and MitoTracker fluorescent images, and are representative of a typical image obtained from five images taken per 
time point, from two independent experiments. Scale bar = 10 μm.Genetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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cytotic and endosomal recycling pathway, but is internal-
ized by an alternative mechanism, such as
macropinocytosis, or in particular a lipid raft/caveolar-
like vesicular uptake, whereby the vesicles are slowly inter-
nalized [37], and do not become acidified [38,39], hence
avoiding lysosomal fusion and subsequent degradation of
the contents within. This mechanism is likely to explain
the random distribution of Arg polyplexes, which was
morphologically not dissimilar to the nocodazole-treated
cells transfected with PEI/pDNA. As opposed to PEI poly-
plexes, PEI-Arg polyplexes may be entrapped within such
vesicles, due to its likely inability to promote vesicle lysis.
Caveolae-mediated internalization is attractive as an alter-
native for DNA delivery, as a significant proportion of
delivered DNA is degraded within the lysosome post-
endosomal transport before it becomes available to the
nucleus. Further analysis will be necessary to ascertain the
true characteristics of these vesicles.
Intact microtubules are essential for specific perinuclear/
MTOC-associated localization of PEI/pDNA polyplexes
The microtubule depolymerizing agent nocodazole was
utilized to investigate potential association between
microtubules and active PEI intracellular trafficking.
Microtubules within nocodazole-treated cells were visual-
ized by immunofluorescence using fluorescent micros-
copy to examine the impact of disrupted microtubules on
PEI trafficking (Figure 3). Untreated mitochondrial, PEI/
pCH110-YOYO, and merged images depict the accumula-
tion of PEI at the MTOC-associated region. The microtu-
Effect of microtubule disrupting agent, nocodazole, on microtubule morphology and PEI polyplex trafficking Figure 3
Effect of microtubule disrupting agent, nocodazole, on microtubule morphology and PEI polyplex trafficking. 
Untreated (A) and nocodazole treated cells (D) displaying normal and disrupted microtubules, highlighted by anti-β-tubulin vis-
ualized using FITC secondary antibody. Nucleus stained with DAPI (B, E) and merged immunofluorescence displayed as (C, F). 
Distribution of PEI/pDNA-YOYO in untreated (G) and nocodazole treated (J) cells with MitoTracker staining (H, K). Merge 
MitoTracker and PEI/pDNA-YOYO in untreated (I) and nocodazole treated (L) cells. Scale bar = 10 μm. Images represent typ-
ical result of two individual slides viewed for each sample, analyzed 5 h post transfection.Genetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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bule controls, showing immunofluorescence of
microtubules, nucleus, and merged images highlight a fil-
amentous-microtubule structure throughout the cell and
an intense staining of microtubule accumulation within a
defined MTOC-associated perinuclear region. Nocoda-
zole-treated cells containing PEI/pDNA-YOYO polyplexes
display a random distribution of labelled complexes
throughout the whole cell, as compared to controls that
display MTOC-associated fluorescence accumulation.
Furthermore, the filamentous morphology of mitochon-
dria stained with MitoTracker was seen to be disrupted,
becoming evenly distributed around the nucleus. The noc-
odazole-treated cells displayed disrupted microtubules,
highlighted by the loss of the filamentous structure and
replaced by a uniform fluorescence throughout the cell.
Randomly dispersed fluorescence of PEI polyplex distri-
bution was observed in nocodazole-treated cells (Figure
3E), as compared to the predictable PEI accumulation at
the MTOC-associated region in non-treated cells (Figure
3B). The significant differences in morphology of micro-
tubules and PEI accumulations observed between the
treated and untreated cells, strongly indicated an albeit
indirect correlation between the disruption of microtu-
bules and loss of PEI trafficking.
As PEI trafficking to the MTOC-associated region occurred
within 4 hours, and that PEI is thought to begin endo-
somal escape at approximately this time [13], we suggest
that PEI is encapsulated within endosomal vesicles at least
until this time point. The association of endosomal traf-
ficking and microtubules is relatively well established,
especially in connection with receptor-mediated endocy-
tosis and subsequent receptor-ligand sorting [40]. We
therefore hypothesize that the active trafficking of PEI
polyplexes is in fact not due to a direct association
between PEI and microtubules, but an indirect associa-
tion, facilitated by PEI localization within the endosomal
compartment at the time of endosomal transport.
GFP expression is largely dependent on proximal nuclear 
accumulation of PEI, and is greatly enhanced by mitotic 
events
Quantitative analysis of gene expression was undertaken
to determine the efficiency of transfection for each poly-
plex bioconjugate. Positive GFP expression was detected
by FACS analysis 24 hours post transfection. Transfection
efficiency was measured by two analyses; (1) percentage
of cells that expressed GFP in the population, and, (2) the
amount of fluorescence per GFP positive cell. The latter
was used to correlate the intensity of GFP fluorescence
with the relative number of plasmid expressing GFP. Both
measures of efficiency are useful and important as it
depends on the therapeutic strategy employed to treat a
particular disorder. Under certain circumstances, it would
be important to obtain high gene expression per cell,
while other strategies benefit from the maximum percent-
age of cells transfected.
As it was initially hypothesized that the Arg peptide would
facilitate and enhance translocation across the plasma
membrane, there would be an increased amount of PEI-
Arg polyplexes available for nuclear uptake. PEI poly-
plexes facilitated significantly greater GFP expression,
with a significantly higher proportion of cells expressing
GFP than PEI-Arg (Figure 4A). GFP expression for each
polyplex type was evident only after an N/P ratio of 3, and
was maintained until N/P 14. In a comparison of the
extent of GFP expression efficiency per cell (Figure 4B),
PEI displayed between 3- and 5-fold more GFP fluores-
cence per transfected cell than PEI-Arg. Surprisingly,
despite facilitating more DNA internalized per cell, PEI-
Arg mediated expression was very inefficient, displaying
no more than 5% of GFP positive cells across the entire N/
P range examined.
The relative high PEI-/low PEI-Arg-facilitated expression
indicates a correlation with the presence, and absence, of
MTOC-associated accumulation respectively, and hence a
possible correlation between microtubule-dependent
intracellular trafficking of polyplexes and GFP expression.
GFP expression analysis of nocodazole treated cells dis-
played a reduction of more than 20% of maximal PEI
expression (Figure 5). This suggests that GFP expression is
not exclusively facilitated by microtubule-dependent traf-
ficking. Taking this into consideration, we expected that
the transfection efficiency of PEI-Arg would have been
greater. As PEI-Arg-facilitated GFP expression averaged 6-
fold less GFP-positive cells (Figure 4B), there must be fur-
ther limitations affecting PEI-Arg that were not directly
evident in this study. This however may be further evi-
dence for the retention of PEI-Arg polyplexes within non-
endocytic vesicles. We hypothesize that expression of
DNA complexed with PEI-Arg entrapped in these vesicles
is hampered, even if they had been engulfed within the
nucleus during mitosis.
The occurrence of significantly higher gene expression
obtained in rapidly dividing cells compared with slow
dividing, or post mitotic cells [1,2] denotes the impor-
tance of the breakdown of the nuclear membrane during
mitosis. To investigate the effect of inhibiting nuclear
membrane breakdown on GFP expression, cell cycle was
arrested at the G1/S checkpoint by the addition of the
anti-mitotic agent aphidicolin. Aphidicolin restricts cells
in the S phase by inhibiting DNA polymerase α, and
hence allows cells at various stages of the cell cycle to accu-
mulate at the G1/S border [41]. GFP expression facilitated
by PEI in the presence of aphidicolin was inhibited up to
80% of maximal PEI-facilitated GFP expression of control
cells (Figure 5), which was comparable to results obtainedGenetic Vaccines and Therapy 2007, 5:11 http://www.gvt-journal.com/content/5/1/11
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from an aphidicolin assessment on cation-lipid mediate
gene delivery [33]. The level of inhibition observed indi-
cates that the efficiency of gene delivery is significantly but
not entirely dependent on mitotic events, as gene expres-
sion was not completely eliminated (8.19% ± 3.95 [SEM,
N = 2]; percentage of GFP positive cells treated with
aphidicolin). It would be of interest to inhibit microtu-
bule transport in post-mitotic cells to further define the
role of microtubules in PEI trafficking.
In light of this, the fact that some cells that do not undergo
cell division, or those that have been prevented from
dividing as seen in this study, can be transfected, indicates
there must be at least one mechanism of polyplex nuclear
entry in the presence of an intact nuclear envelope. God-
bey et al. [13] hypothesize that polyplex interactions with
phospholipids may facilitate nuclear uptake. The coating
of cationic polyplexes with anionic lipids may facilitate
interactions with the lipid and nuclear membrane, which
may ultimately release the polyplex into the nucleus. They
speculated that the coating could be either via interactions
with free phospholipids that are constantly being synthe-
sized for membrane regeneration, or that tight interac-
tions with endosomal phospholipids after endosomolysis
may be responsible. Another potential route is via the
nuclear pore complex (NPC), which may facilitate diffu-
sive or active uptake of polyplexes [1]. The latter, however,
seems to be unlikely, as only particles smaller than 9 nm
in diameter can readily diffuse through the NPC, which
Effect of nocodazole and aphidicolin on PEI polyplex medi- ated GFP expression Figure 5
Effect of nocodazole and aphidicolin on PEI polyplex 
mediated GFP expression. Expression of GFP 24 h post 
transfection in the presence of nocodazole (light bar), or 
aphidicolin (dark bar), as a percentage of optimal PEI/pDNA 
mediated GFP expression at N/P 8. Data obtained as 
detected by FACS 24 h post transfection, and represented as 
mean values ± SEM (N = 2).
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Gene expression efficiency mediated by PEI- and PEI-Arg polyplexes Figure 4
Gene expression efficiency mediated by PEI- and PEI-Arg polyplexes. The percentage of GFP positive cells (A) and 
the relative amount of fluorescence per GFP positive cell (B) was calculated for polyplexes composed of PEI ( ) and PEI-Arg ( ) 
complexed with pEOTCGFP, as detected by FACS 24 h post transfection. Data represented as mean values ± SEM (N = 3).
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excludes the significantly larger polyplexes. Furthermore,
active transport through the NPC requires the activation
of energy-dependent transport mechanisms, a step in
which is unlikely to occur for PEI-mediated transfection.
Conclusion
Internalization of polyplexes was observed to be highly
efficient for both PEI and PEI-Arg. The conjugation of Arg
to PEI did not negatively affect internalization, and we
have demonstrated that the attachment of Arg peptides to
PEI increased polyplexes internalized, resulting in more
DNA per cell. We speculate however that the attachment
of the Arg peptides alters the mechanism by which PEI
polyplexes enter the cell, and that this alternative mecha-
nism is responsible for the altered biodistribution of PEI-
Arg/pDNA polyplexes.
Active motor driven transport of PEI by microtubules has
been suggested previously [11]. Conversely, we suggest
that PEI trafficking is solely a consequence of PEI-encap-
sulated endosomal transport facilitated by microtubules,
rather than a direct PEI-microtubule association. There-
fore, the differences observed between the efficacy of PEI
and PEI-Arg is likely to be largely due to the absence of
microtubule trafficking of PEI-Arg polyplexes.
From this, we surmise that the absence of microtubule-
facilitated trafficking of PEI-Arg polyplexes is the result of
a lack of PEI-like endosomal compartmentalization, ulti-
mately because of a difference in internalization mecha-
nism. Moreover, this alternative internalization ultimately
results in the significant reduction in gene expression
observed, compared to that seen with PEI/pDNA poly-
plexes, and is likely due to a retention or entrapment
within such vesicles. Such entrapment further supports
the observation of cytoplasmic vesicular retention of Arg
peptides in live cell studies [29,30].
Finally, we hypothesize that microtubules do not directly
influence nuclear uptake, but facilitate proximal nuclear
accumulation so that there is a greater probability of
either nuclear capture during mitosis, or of direct interac-
tion of polyplexes with the nuclear membrane itself.
Conjugation of peptides to PEI offers a promising
approach to improve the transfection efficiency and ulti-
mately the viability of an effective non-viral gene therapy
strategy, despite some of the obstacles identified in this
study. It can be speculated that clinical gene therapy appli-
cations will involve the use of a multi-component vector;
each constituent contributing a specialized property that
utilizes an individual innate cellular pathway or function,
to provide specific and efficient delivery of therapeutic
genes to the nucleus.
Continued investigation is needed to further characterize
cellular pathways of PEI and other non-viral vectors. This
will in turn, further identify important bottlenecks of
transfection efficiency allowing new and improved strate-
gies to be developed. Only with the support of gene deliv-
ery research will the gap between the promise and the
clinical application of gene therapy be realized for many
currently untreatable genetic diseases.
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